0001209191-20-007324.txt : 20200206
0001209191-20-007324.hdr.sgml : 20200206
20200206200340
ACCESSION NUMBER: 0001209191-20-007324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200204
FILED AS OF DATE: 20200206
DATE AS OF CHANGE: 20200206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Eric A
CENTRAL INDEX KEY: 0001751486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 20584279
MAIL ADDRESS:
STREET 1: 7 CALEB CIRCLE
CITY: SAN ANTONIO
STATE: TX
ZIP: 78258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-04
0
0000876378
TRANSENTERIX, INC.
TRXC
0001751486
Smith Eric A
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
Chief Commercial Officer
Common Stock
2020-02-04
4
M
0
12821
0.00
A
12821
D
Common Stock
2020-02-04
4
F
0
4486
1.28
D
8335
D
Restricted Stock Units
0.00
2020-02-04
4
A
0
8975
0.00
D
Common Stock
8975
17949
D
Restricted Stock Units
0.00
2020-02-04
4
A
0
1282
0.00
D
Common Stock
1282
2565
D
Restricted Stock Units
0.00
2020-02-04
4
A
0
2564
0.00
D
Common Stock
2564
5129
D
Effective December 11, 2019, the Registrant effected a reverse stock split of its common stock at a ratio of one-for-thirteen shares. The amounts set forth in this Form 4 have been adjusted to reflect the reverse stock split.
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the
underlying shares.
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
Lapse of forfeiture restrictions on one-third of a RSU award granted on February 6, 2019. Forfeiture restrictions will lapse on the remaining RSUs in two installments of 8,974 and 8,975 on each of February 4, 2021 and 2022, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company.
Lapse of forfeiture restrictions on one-third of a RSU award granted on November 2, 2018. Forfeiture restrictions will lapse on the remaining RSUs in two installments of 1,282 and 1,283 on each of July 3, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company.
Lapse of forfeiture restrictions on one-third of a RSU award granted on August 31, 2018. Forfeiture restrictions will lapse on the remaining RSUs in two installments of 2,564 and 2,565 on each of August 31, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company.
/s/Joshua Weingard, as Attorney-in-Fact for Eric A. Smith
2020-02-06